Sign inGet started

Kronenfeld Mark A.

Insider CIK 1578074 · PCRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PCRX Pacira BioSciences, Inc. A Award2025-06-112026-03-196,163— $031,065SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2025-06-112025-06-1311,279— $011,279SEC↗
PCRX Pacira BioSciences, Inc. A Award2025-06-112025-06-139,999— $034,901SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2024-06-122024-06-1312,179— $012,179SEC↗
PCRX Pacira BioSciences, Inc. A Award2024-06-122024-06-135,230— $024,902SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2023-06-142023-06-1612,925— $012,925SEC↗
PCRX Pacira BioSciences, Inc. A Award2023-06-142023-06-161,775— $019,672SEC↗
PCRX Pacira BioSciences, Inc. M Exercise deriv2023-06-082023-06-1215,000— $00SEC↗
PCRX Pacira BioSciences, Inc. S Sale2023-06-082023-06-1215,000$37.04 $555.6K17,897SEC↗
PCRX Pacira BioSciences, Inc. M Exercise2023-06-082023-06-1215,000$29.90 $448.5K32,897SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2022-06-082022-06-088,225— $08,225SEC↗
PCRX Pacira BioSciences, Inc. A Award2022-06-082022-06-081,160— $017,897SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2021-06-092021-06-117,626— $07,626SEC↗
PCRX Pacira BioSciences, Inc. A Award2021-06-092021-06-111,066— $016,737SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2020-06-092020-06-118,027— $08,027SEC↗
PCRX Pacira BioSciences, Inc. A Award2020-06-092020-06-111,260— $015,671SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2019-06-052019-06-068,437— $08,437SEC↗
PCRX Pacira BioSciences, Inc. A Award2019-06-052019-06-064,134— $014,411SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2019-03-062019-03-081,000$39.14 $39.1K10,277SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2019-03-062019-03-08700$38.72 $27.1K9,277SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2018-08-282018-08-301,000$44.61 $44.6K8,577SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2018-06-132018-06-154,693— $04,693SEC↗
PCRX Pacira Pharmaceuticals, In A Award2018-06-132018-06-15782— $07,577SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2017-11-102017-11-131,000$41.60 $41.6K6,795SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2017-06-142017-06-162,714— $02,714SEC↗
PCRX Pacira Pharmaceuticals, In A Award2017-06-142017-06-161,357— $05,795SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2016-06-152016-06-172,975— $02,975SEC↗
PCRX Pacira Pharmaceuticals, In A Award2016-06-152016-06-171,488— $04,438SEC↗
PCRX Pacira Pharmaceuticals, In S Sale2016-06-062016-06-08900$46.95 $42.3K2,950SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2015-06-032015-06-054,000— $04,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award2015-06-032015-06-052,000— $03,850SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2014-11-032014-11-04850$90.48 $76.9K1,850SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2014-06-032014-06-058,000— $08,000SEC↗
PCRX Pacira Pharmaceuticals, In P Buy2013-09-112013-09-131,000$37.01 $37.0K1,000SEC↗
PCRX Pacira Pharmaceuticals, In A Award deriv2013-06-122013-06-1415,000— $015,000SEC↗